Skip to main content
. 2022 Jun 27;72(3):512–521. doi: 10.1136/gutjnl-2021-326522

Figure 2.

Figure 2

Five-year time trends of mean BMI and blood markers (HbA1c, bilirubin, haemoglobin, white blood cell and platelets) prior to index month in PDAC cases versus controls by type 2 diabetes status (recent onset, long-standing, none). BMI, body mass index; HbA1c, haemoglobin A1c; PDAC, pancreatic ductal adenocarcinoma.